Viewing Study NCT01326767


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-01-01 @ 2:30 AM
Study NCT ID: NCT01326767
Status: COMPLETED
Last Update Posted: 2016-01-27
First Post: 2011-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring
Sponsor: Central European Society for Anticancer Drug Research
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: C-III-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View